Autoimmune Hepatitis Linked to Increased HPV and Cervical Dysplasia Risk in Women

Research presented at Digestive Disease Week in Chicago indicates that women with autoimmune hepatitis (AIH) may face a higher likelihood of developing cervical dysplasia and human papillomavirus (HPV) infections compared to those without the condition.

The data further suggests that women with AIH appear more likely to experience abnormal pap smear results and undergo colposcopy, a procedure used to examine the cervix, vagina and vulva for signs of disease.

The Connection Between AIH and Cervical Health

Autoimmune hepatitis is a chronic disease in which the body’s immune system attacks liver cells, leading to inflammation and potential liver damage. The condition is significantly more common in women, appearing four times more prevalent among women than men.

Beyond liver health, AIH has been previously linked to an increased risk of both intrahepatic and extrahepatic malignancies, which are cancers located inside and outside the liver, respectively.

The newly presented findings highlight a specific vulnerability regarding cervical health. Cervical dysplasia refers to the presence of abnormal cells on the surface of the cervix, which can be precursors to cervical cancer.

The Role of Immunosuppression and HPV

A primary factor in the management of autoimmune hepatitis is the use of medications to dampen the immune response. These treatments are essential for controlling liver inflammation but may influence how the body interacts with viral infections.

A cornerstone of AIH treatment is immunosuppression, and HPV infection can play a large role in cervical cancer

Digestive Disease Week presentation

HPV is the primary cause of most cervical cancers. Because immunosuppressive therapies reduce the body’s ability to fight off infections, there is a theoretical and observed link between these treatments and a higher susceptibility to HPV persistence or the development of dysplastic changes in the cervix.

The observation that women with AIH are more likely to have abnormal pap smears and require colposcopies underscores the potential need for heightened surveillance in this patient population.

Regular screening via pap smears and HPV testing is the standard for detecting cervical dysplasia early, allowing for interventions before abnormal cells progress to malignancy.